These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 30828570)
21. Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of commonly encountered, clinically important yeast species. Hall L; Wohlfiel S; Roberts GD J Clin Microbiol; 2003 Nov; 41(11):5099-102. PubMed ID: 14605145 [TBL] [Abstract][Full Text] [Related]
22. Application of MALDI-TOF MS for requalification of a Candida clinical isolates culture collection. Lima-Neto R; Santos C; Lima N; Sampaio P; Pais C; Neves RP Braz J Microbiol; 2014; 45(2):515-22. PubMed ID: 25242936 [TBL] [Abstract][Full Text] [Related]
23. Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogotá, Colombia. Rodríguez-Leguizamón G; Fiori A; López LF; Gómez BL; Parra-Giraldo CM; Gómez-López A; Suárez CF; Ceballos A; Van Dijck P; Patarroyo MA BMC Microbiol; 2015 Oct; 15():199. PubMed ID: 26438104 [TBL] [Abstract][Full Text] [Related]
24. Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories? Mizusawa M; Miller H; Green R; Lee R; Durante M; Perkins R; Hewitt C; Simner PJ; Carroll KC; Hayden RT; Zhang SX J Clin Microbiol; 2017 Feb; 55(2):638-640. PubMed ID: 27881617 [No Abstract] [Full Text] [Related]
25. Usefulness of CHROMagar Candida Medium, Biochemical Methods--API ID32C and VITEK 2 Compact and Two MALDI-TOF MS Systems for Candida spp. Identification. Stefaniuk E; Baraniak A; Fortuna M; Hryniewicz W Pol J Microbiol; 2016; 65(1):111-4. PubMed ID: 27282002 [TBL] [Abstract][Full Text] [Related]
26. [Evaluation of mass spectrometry: MALDI-TOF MS for fast and reliable yeast identification]. Relloso MS; Nievas J; Fares Taie S; Farquharson V; Mujica MT; Romano V; Zarate MS; Smayevsky J Rev Argent Microbiol; 2015; 47(2):103-7. PubMed ID: 25882136 [TBL] [Abstract][Full Text] [Related]
27. Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP. De Carolis E; Hensgens LA; Vella A; Posteraro B; Sanguinetti M; Senesi S; Tavanti A Med Mycol; 2014 Feb; 52(2):123-30. PubMed ID: 24577004 [TBL] [Abstract][Full Text] [Related]
28. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis. Shi Y; Zhu Y; Fan S; Liu X; Liang Y; Shan Y BMC Infect Dis; 2020 Apr; 20(1):287. PubMed ID: 32393342 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures. Yaman G; Akyar I; Can S Diagn Microbiol Infect Dis; 2012 May; 73(1):65-7. PubMed ID: 22578939 [TBL] [Abstract][Full Text] [Related]
30. [Evaluation of Agar Candida ID2 (bioMerieux) a chromogenic medium for yeasts differentiation]. Ciok-Pater E; Zalas P; Gospodarek E Med Dosw Mikrobiol; 2006; 58(3):247-51. PubMed ID: 17341000 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of a new matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for the identification of yeast isolation. Lee H; Park JH; Oh J; Cho S; Koo J; Park IC; Kim J; Park S; Choi JS; Shin SY; Sung GH; Kim J J Clin Lab Anal; 2019 Feb; 33(2):e22685. PubMed ID: 30298531 [TBL] [Abstract][Full Text] [Related]
32. Multiplex size marker (YEAST PLEX) for rapid and accurate identification of pathogenic yeasts. Aboutalebian S; Mahmoudi S; Charsizadeh A; Nikmanesh B; Hosseini M; Mirhendi H J Clin Lab Anal; 2022 May; 36(5):e24370. PubMed ID: 35318737 [TBL] [Abstract][Full Text] [Related]
33. Identification of nine cryptic species of Candida albicans, C. glabrata, and C. parapsilosis complexes using one-step multiplex PCR. Arastehfar A; Fang W; Pan W; Liao W; Yan L; Boekhout T BMC Infect Dis; 2018 Sep; 18(1):480. PubMed ID: 30253748 [TBL] [Abstract][Full Text] [Related]
34. MALDI-TOF MS Overcomes Misidentification of the Uncommon Human Pathogen Candida famata by Routine Phenotypic Identification Methods. Ghaith D; Zafer MM; Hosny T; AbdElfattah M Curr Microbiol; 2021 Apr; 78(4):1636-1642. PubMed ID: 33687510 [TBL] [Abstract][Full Text] [Related]
35. [Comparison of different methods for the identification of Candida species isolated from clinical specimens]. Cetinkaya Z; Altindiş M; Aktepe OC; Karabiçak N Mikrobiyol Bul; 2003 Oct; 37(4):269-76. PubMed ID: 14748264 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the first Candida auris isolates reported from Türkiye in terms of identification by various methods and susceptibility to antifungal drugs. Erkose Genc G; Caklovica Kucukkaya I; Komec S; Toker Onder I; Toptas O; Teke L; Turan D; Aygun G; Gulmez D; Arikan Akdagli S; Erturan Z Indian J Med Microbiol; 2024; 49():100594. PubMed ID: 38636843 [TBL] [Abstract][Full Text] [Related]
37. [Comparison of Phoenix™ Yeast ID Panel and API® ID 32C commercial systems for the identification of Candida species isolated from clinical samples]. Gayibova Ü; Dalyan Cılo B; Ağca H; Ener B Mikrobiyol Bul; 2014 Jul; 48(3):438-48. PubMed ID: 25052110 [TBL] [Abstract][Full Text] [Related]
38. Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory. Wadlin JK; Hanko G; Stewart R; Pape J; Nachamkin I J Clin Microbiol; 1999 Jun; 37(6):1967-70. PubMed ID: 10325356 [TBL] [Abstract][Full Text] [Related]
39. Comparative evaluation of two matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) systems for the identification of clinically significant yeasts. Jamal WY; Ahmad S; Khan ZU; Rotimi VO Int J Infect Dis; 2014 Sep; 26():167-70. PubMed ID: 25080355 [TBL] [Abstract][Full Text] [Related]
40. Identification of yeast isolated from dermatological patients by MALDI-TOF mass spectrometry. Seyfarth F; Wiegand C; Erhard M; Gräser Y; Elsner P; Hipler UC Mycoses; 2012 May; 55(3):276-80. PubMed ID: 21848605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]